Idaho Bills

Adds to existing law to establish a moratorium on certain uses of human gene therapy products.

This legislation establishes a temporary moratorium on the administration of certain human gene therapy products for infectious disease indications to children under eighteen (18) years of age and to pregnant women. The bill adds a new section to Chapter 48, Title 39, Idaho Code, to prohibit the administration of such products regardless of route or modality and regardless of whether the administration is termed an immunization, vaccine, or any other term. The legislation provides that the moratorium shall remain in effect for two (2) years while available safety data is reviewed. The moratorium does not apply to human gene therapy products used for the treatment or therapy of cancer or genetic disorders. The legislation further provides a process by which an individual human gene therapy product may be exempted from the moratorium upon legislative review of safety data, informed consent procedures, and compensation assurances for adverse outcomes.